SCHEMBL4121438

SCHEMBL4121438

O=C(O)Nc1ccc(Cl)cc1C(O)c1cccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GRIK1 P39086 1/20 0.46
RAB9A P51151 1/20 0.46
POLB P06746 1/20 0.43
G6PD P11413 1/20 0.43
SERPINE1 P05121 1/20 0.43
TRPM4 Q8TD43 1/20 0.41
TRPV1 Q8NER1 2/20 0.40
ALOX5 P09917 2/20 0.40
PPARG P37231 2/20 0.40
PTGES O14684 1/20 0.40
IDH1 O75874 1/20 0.39
LPAR1 Q92633 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ACP3 P15309 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
IDO1 P14902 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13776051 0.83 KMT2A (0.40) MEN1KMT2AGRIK1RAB9AALDH1A1
SCHEMBL13776424 0.83 HSP90AA1 (0.43) MEN1KMT2AGRIK1RAB9APOLB
SCHEMBL4129117 0.82 LPAR1 (0.38) MEN1KMT2AGRIK1LPAR1ALDH1A1
SCHEMBL4122916 0.80 LPAR1 (0.56) MEN1KMT2AGRIK1PPARGLPAR1
SCHEMBL4113798 0.79 GRIK1 (0.47) GRIK1RAB9APOLBALDH1A1KDM4E
SCHEMBL4125981 0.79 KMT2A (0.42) MEN1KMT2AGRIK1RAB9ALPAR1
SCHEMBL8685502 0.77 KMT2A (0.39) MEN1KMT2ARAB9APOLBG6PD
SCHEMBL4116747 0.77 LPAR1 (0.45) MEN1KMT2ARAB9ALPAR1ALDH1A1
SCHEMBL4123090 0.77 LPAR1 (0.50) MEN1KMT2AGRIK1PPARGLPAR1
SCHEMBL4125868 0.77 LPAR1 (0.50) MEN1KMT2AGRIK1LPAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR MEN1 2041/4885KMT2A 1467/4885GRIK1 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.